Robert W. Bryant

3.3k total citations
60 papers, 2.6k citations indexed

About

Robert W. Bryant is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Robert W. Bryant has authored 60 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Pharmacology and 17 papers in Biochemistry. Recurrent topics in Robert W. Bryant's work include Eicosanoids and Hypertension Pharmacology (16 papers), Inflammatory mediators and NSAID effects (13 papers) and Biochemical Analysis and Sensing Techniques (5 papers). Robert W. Bryant is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (16 papers), Inflammatory mediators and NSAID effects (13 papers) and Biochemical Analysis and Sensing Techniques (5 papers). Robert W. Bryant collaborates with scholars based in United States, United Kingdom and France. Robert W. Bryant's co-authors include Jennifer M. Bailey, Jack Y. Vanderhoek, J. Martyn Bailey, Marvín I. Siegel, T Schewe, S. Rapoport, Motasim Billah, Theodore C. Simon, Laurent Meijer and Jacques Maclouf and has published in prestigious journals such as Science, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Robert W. Bryant

60 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert W. Bryant United States 26 872 706 589 424 392 60 2.6k
Homer S. Black United States 34 992 1.1× 171 0.2× 161 0.3× 501 1.2× 197 0.5× 110 3.2k
Maurice Wibo Belgium 27 2.3k 2.6× 348 0.5× 171 0.3× 182 0.4× 654 1.7× 67 3.9k
F.A. Fitzpatrick United States 41 1.8k 2.1× 887 1.3× 1.4k 2.4× 368 0.9× 1.0k 2.6× 99 4.9k
C.R. Pace-Asciak Canada 42 2.0k 2.3× 1.7k 2.4× 1.7k 3.0× 499 1.2× 1.1k 2.8× 188 6.1k
Carlos Batthyány Uruguay 26 1.4k 1.6× 809 1.1× 160 0.3× 332 0.8× 940 2.4× 64 2.8k
D. A. van Dorp Netherlands 25 1.0k 1.2× 853 1.2× 1.3k 2.2× 372 0.9× 343 0.9× 60 3.1k
Elizabeth A. Shephard United Kingdom 35 1.8k 2.1× 385 0.5× 184 0.3× 210 0.5× 496 1.3× 116 4.0k
Wolf‐Hagen Schunck Germany 37 1.8k 2.0× 1.8k 2.6× 402 0.7× 803 1.9× 455 1.2× 113 4.8k
Pia Hartzell Sweden 16 2.2k 2.6× 218 0.3× 110 0.2× 446 1.1× 297 0.8× 16 3.9k
W. Elaine Hardman United States 30 743 0.9× 180 0.3× 162 0.3× 762 1.8× 313 0.8× 76 2.2k

Countries citing papers authored by Robert W. Bryant

Since Specialization
Citations

This map shows the geographic impact of Robert W. Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Bryant more than expected).

Fields of papers citing papers by Robert W. Bryant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Bryant. The network helps show where Robert W. Bryant may publish in the future.

Co-authorship network of co-authors of Robert W. Bryant

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Bryant. A scholar is included among the top collaborators of Robert W. Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Bryant. Robert W. Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palmer, R. Kyle, et al.. (2013). A High Throughput In Vivo Assay for Taste Quality and Palatability. PLoS ONE. 8(8). e72391–e72391. 13 indexed citations
2.
Cerne, Rok, et al.. (2010). Overexpression of Human Transient Receptor Potential M5 Upregulates Endogenous Human Transient Receptor Potential A1 in a Stable HEK Cell Line. Assay and Drug Development Technologies. 8(6). 695–702. 4 indexed citations
3.
Palmer, R. Kyle, Karnail S. Atwal, Rok Cerne, et al.. (2010). Triphenylphosphine Oxide Is a Potent and Selective Inhibitor of the Transient Receptor Potential Melastatin-5 Ion Channel. Assay and Drug Development Technologies. 8(6). 703–713. 60 indexed citations
4.
Brennan, Francis X., et al.. (2009). Pharmacologic Antagonism of the Oral Aversive Taste-Directed Response to Capsaicin in a Mouse Brief Access Taste Aversion Assay. Journal of Pharmacology and Experimental Therapeutics. 332(2). 525–530. 12 indexed citations
5.
Qian, Yang, et al.. (2008). Thymol and related alkyl phenols activate the hTRPA1 channel. British Journal of Pharmacology. 153(8). 1739–1749. 138 indexed citations
6.
Brennan, Francis X., et al.. (2008). Quantitative assessment of TRPM5-dependent oral aversiveness of pharmaceuticals using a mouse brief-access taste aversion assay. Behavioural Pharmacology. 19(7). 673–682. 25 indexed citations
7.
Bryant, Robert W., et al.. (2004). WGA-Coated Yttrium Oxide Beads Enable an Imaging-Based Adenosine 2a Receptor Binding Scintillation Proximity Assay Suitable for High Throughput Screening. Assay and Drug Development Technologies. 2(3). 290–299. 8 indexed citations
8.
9.
Bryant, Robert W., et al.. (2003). Development of a Fluorescence Polarization AKT Serine/Threonine Kinase Assay Using an Immobilized Metal Ion Affinity-Based Technology. Assay and Drug Development Technologies. 1(4). 545–553. 18 indexed citations
10.
Small, Eliza C., et al.. (2003). Evaluation of Fluorescent Compound Interference in 4 Fluorescence Polarization Assays: 2 Kinases, 1 Protease, and 1 Phosphatase. SLAS DISCOVERY. 8(2). 176–184. 85 indexed citations
11.
12.
13.
Jenh, Chung‐Her, Meng Zhang, Maria Wiekowski, et al.. (1998). Development of a CD28 Receptor Binding-Based Screen and Identification of a Biologically Active Inhibitor. Analytical Biochemistry. 256(1). 47–55. 12 indexed citations
14.
Silver, Jack, Mahesh Patel, Robert W. Bryant, et al.. (1995). Phospholipase D Inhibitors from a Myrsine Species. Journal of Natural Products. 58(10). 1492–1497. 15 indexed citations
15.
Smith, Steve, et al.. (1992). Actions of a 5-lipoxygenase inhibitor, Sch 40120, on acute inflammatory responses.. Journal of Pharmacology and Experimental Therapeutics. 262(2). 721–728. 7 indexed citations
16.
Bryant, Robert W., et al.. (1990). Phorbol esters increase synthesis of decay-accelerating factor, a phosphatidylinositol-anchored surface protein, in human endothelial cells.. The Journal of Immunology. 144(2). 593–598. 20 indexed citations
17.
Sherlock, Margaret H., et al.. (1988). Antiallergy agents. 1. Substituted 1,8-naphthyridin-2(1H)-ones as inhibitors of SRS-A release. Journal of Medicinal Chemistry. 31(11). 2108–2121. 75 indexed citations
18.
Anthes, John C., Robert W. Bryant, Mark W. Musch, Kwokei Ng, & Marvín I. Siegel. (1986). Calcium ionophore and chemotactic peptide stimulation of peptidoleukotriene synthesis in DMSO-differentiated HL60 cells. Inflammation. 10(2). 145–156. 22 indexed citations
19.
Meijer, Laurent, Alan Brash, Robert W. Bryant, et al.. (1986). Stereospecific induction of starfish oocyte maturation by (8R)-hydroxyeicosatetraenoic acid.. Journal of Biological Chemistry. 261(36). 17040–17047. 73 indexed citations
20.
Bryant, Robert W.. (1964). Densities obtained from drag on the Explorer 17 satellite. Journal of Geophysical Research Atmospheres. 69(7). 1423–1425. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Homer S. Black Breakdown of academic impact, for papers by Maurice Wibo Breakdown of academic impact, for papers by F.A. Fitzpatrick Breakdown of academic impact, for papers by C.R. Pace-Asciak Breakdown of academic impact, for papers by Carlos Batthyány Breakdown of academic impact, for papers by D. A. van Dorp Breakdown of academic impact, for papers by Elizabeth A. Shephard Breakdown of academic impact, for papers by Wolf‐Hagen Schunck Breakdown of academic impact, for papers by Pia Hartzell Breakdown of academic impact, for papers by W. Elaine Hardman
Rankless by CCL
2026